BACKGROUND: Obesity is associated with insulin resistance and premature atherosclerosis. The human adipose tissue produce several adipokines including monocyte chemoattractant protein (MCP)-1, associated with cardiovascular disease and found to be involved in the pathogenesis of atherosclerosis in vitro. OBJECTIVE: (1) To compare mRNA levels of MCP-1, leptin and a macrophage-specific marker (CD68) in isolated adipocytes vs stromal-vascular (SV) cells, (2) to compare mRNA levels of MCP-1 in human adipose tissue to circulating MCP-1 and adiposity (eg BMI: kg/m 2 ) and (3) investigate the effect of weight loss in obese subjects on circulating MCP-1 and leptin. RESULTS: (1) MCP-1 and CD68 mRNA levels in isolated adipocytes vs SV cells were 17% (Po0.01) and B2% (Po0.001), respectively. Leptin mRNA levels in SV cells were B1% of that in isolated adipocytes (Po0.01). (2) MCP-1 mRNA levels correlated with circulating MCP-1 (Po0.05) and BMI (Po0.05). (3) A 12% weight loss (Po0.001) was associated with a 25% decrease in insulin levels (Po0.01). Circulating MCP-1 and leptin decreased by 20% (Po0.001) and by 24% (Po0.001), respectively. DISCUSSION: The findings demonstrate that MCP-1 is produced in isolated human adipocytes. In addition, the findings suggest that MCP-1 may be involved in obesity-related health complications and support the hypothesis that weight loss is beneficial by improving the low-grade inflammation observed in obesity.
Introduction
Obesity, especially visceral obesity, is accompanied by a variety of metabolic disturbances such as insulin resistance, dyslipidemia and development of premature atherosclerosis. 1 Moreover, obesity is associated with a low-grade inflammatory process mediated by increased levels of chemokines and cytokines, which presumably is related to the enhanced atherosclerosis found in obese subjects. 2 Besides the role as a storage organ, human adipose tissue releases a number of bioactive proteins (adipokines) including tumor necrosis factor (TNF)-a, 3 interleukin (IL)-6 4 and IL-8, 5 some of which have been reported to be affected by weight loss in obese subjects 3, 4, 6 and therefore could be of more general importance in the link between obesity and health complications. Monocyte chemoattractant protein (MCP)-1 is a proinflammatory chemokine, mainly produced by macrophages and endothelial cells, and suggested to be involved in the pathogenesis of atherosclerosis in vitro 7, 8 and associated with cardiovascular disease in vivo. 9 Gerhardt et al found MCP-1 also to be produced and released from human preadipocytes as well as isolated mature adipocytes 10 adding it to the list of adipokines. MCP-1 is elevated in type-2 diabetic patients 11 and suggested to be involved in regulation of insulin sensitivity in 3T3-L1 adipocytes in vitro. 12, 13 Recently, MCP-1 was demonstrated to be elevated in animal models of obesity (ob/ob mice and diet-induced obesity (DIO) mice) 12, 14 and weight loss in DIO mice has been found to reduce circulating MCP-1. 14 The primary aim of the present study was to investigate the relationship between MCP-1 production in human-isolated adipocytes and stromal-vascular (SV) cells, and for comparison an adipose-specific protein (leptin) and a macrophage-specific marker (CD68) were investigated in parallel. Secondly, the relationship between MCP-1 mRNA levels in human adipose tissue, circulating MCP-1 and measures of adiposity (eg body mass index (BMI): kg/m 2 ) were investigated. Finally, the effect of weight loss in morbid obese subjects on circulating MCP-1 and for comparison leptin were investigated. 2 ) participated in the first part of the study. All subjects were fasted overnight before tissue removal. The subjects were fasted overnight before blood sampling and adipose tissue biopsy. As previously described, 5 the skin was anesthetized with lidocain (10 mg/ml) before a small incision was made and B10 g of tissue was removed by a needle to which partial vacuum was applied.
Subjects and methods

Subjects
Study 3.
A total of 23 (13 women and 10 men) nondiabetic morbid obese Caucasian subjects (mean age 34.578.7 y and mean BMI: 51.176.4 kg/m 2 ) were included in the study. The subjects participated in a life-style intervention for 12 weeks consisting of a 9.2 MJ day diet combined with moderate physical exercise for at least 2 h/day. At baseline and again after 12 weeks, body composition was estimated by bioelectric impedance using a multifrequency bioimpedance spectroscopy analyser (SFB3, UniQuest Limited, Brisbane, Australia) and fasting blood samples were obtained between 0700 and 0900 hours. None of the subjects had any metabolic disorders or received any medication known to influence adipose tissue metabolism. The study had been approved by the Ethical committee of Aarhus.
Preparation of isolated adipocytes and SV cells
Adipocytes were isolated from whole adipose tissue cultures as described in Bruun et al. 5 The isolated adipocytes were resuspended in medium 199 containing 1% bovine serum albumin and 25 mM Hepes. Finally, the 200 ml cell suspension containing 10% adipose cells, corresponding to B100 000 adipocytes in each tube, was snap-frozen in liquid nitrogen and kept at À801C for later RNA extraction. After the initial collagenase digestion, the SV fraction remaining was centrifuged for 15 min at 6300 g, resuspended in 9 ml buffer and filtered through a nylon mesh. This procedure was repeated three times after which the supernatant was removed and the SV fraction was snap-frozen in liquid nitrogen and kept at À801C for later RNA extraction.
Determination of protein and mRNA levels All blood and tissue samples were stored at À20 and À801C, respectively. MCP-1 protein was assessed using a human enzyme-linked immunosorbent assay (ELISA) method (R&D Systems Europe Ltd., UK) with an intra-assay coefficient of variation of 8.1% (n ¼ 12). Leptin protein was assessed using a human radioimmunoassay (RIA) method (Linco Research Ltd., St Charles, MO, USA) with an intra-assay coefficient of variation of 6.4% (n ¼ 10). RNA was isolated using Trizol reagent and real-time reverse transcriptase PCR (RT-PCR) cDNA was made with random hexamer primers as described (GeneAmp PCR kit, PerkinElmer Cetus, Norwalk CT, USA). PCR mastermix containing the specific primers, Hot Star Taq DNA polymerase and SYBRGreen was then added. As previously described, 15 real-time quantification was performed with an SYBR-Green real-time PCR assay using an ICycler PCR machine from Bio-Rad (BioRad Laboratories, Inc., CA, USA). The following oligonucleotide primer pairs were used: MCP-1:
0 . Relative mRNA levels of MCP-1, leptin and CD68 to b-actin were calculated as described in User Bulletin #2, 1997 from Perkin-Elmer (Perkin-Elmer Cetus, Norwalk CT, USA). Samples were amplified in duplicate.
Statistical analysis
The SPSS statistical packet (SPSS, Chicago, IL, USA) was used for the calculations. To determine the relationship between BMI and MCP-1 mRNA or plasma levels, a bivariate correlation with a Pearson correlation coefficient (r p ) was used. A paired t-test was used for comparison between mRNA levels in adipocytes compared to the SV fraction and for comparison between MCP-1 and leptin levels at baseline and after weight loss. Threshold for significance was set at Po0.05.
Results
Study 1. MCP-1 mRNA levels were found to be 17% in isolated adipocytes as compared to SV cells (Po0.01, Figure 1 ). As expected, leptin production in SV cells was very low (B1%) as compared to isolated adipocytes (Po0.01, Figure 1 ) and almost no CD68 production (B2%) was found in isolated adipocytes as compared to SV cells (Po0.001, Figure 1 ). Figure 2 , MCP-1 mRNA levels in subcutaneous adipose tissue correlated significantly with both circulating MCP-1 (Po0.05, Figure 2a) and BMI (Po0.05, Figure 2b ). In addition, circulating MCP-1 was also found to correlate with BMI (Po0.05, Figure 2c ). 
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Study 2. As shown in
Discussion
In the present study, parallel investigations on the production of an adipokine (MCP-1), an adipose-specific protein (leptin) and a macrophage-specific marker (CD68) were performed in isolated adipocytes vs the corresponding SV fraction. It was for the first time demonstrated that MCP-1 mRNA levels in isolated adipocytes were approximately 17% of that in SV cells, which essentially is in line with a previous report on other adipokines. 16 Other novel findings were the association between MCP-1 mRNA levels in human adipose tissue, circulating MCP-1 and BMI. In addition, circulating MCP-1 and leptin were decreased after weight reduction obtained through hypocaloric diet combined with moderate physical activity in morbid obese subjects. The relationship between adiposity (BMI) and adipose or circulating MCP-1 is in agreement with recent rodent studies using ob/ob and DIO mice. 12, 14 The only human study addressing adiposity and 
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A growing body of evidence suggests the importance of inflammatory processes in the pathogenesis of atherosclerosis and cardiovascular disease 18 and MCP-1 has been demonstrated to participate in the atherosclerotic process. 7, 8 The reported decrement in MCP-1 levels in the present study is comparable to other weight loss-induced changes in circulating adipokines. 4, 6 However, even though Sartipy and Loskutoff found 10-to 100-fold higher MCP-1 expression in adipose tissue from ob/ob mice compared to other tissues 12 and MCP-1 has been found to be released from human adipose tissue. 10 A recent study by Weisberg et al demonstrated correlations between obesity and the number of macrophages within human adipose tissue. 19 The present finding that CD68 production was B50-fold higher in SV cells compared to isolated adipocytes is in line with that study, and together with the observed five-fold higher MCP-1 production in SV cells vs isolated adipocytes suggests that macrophage MCP-1 production may be primarily responsible for the present association between MCP-1 and adiposity. However, regardless from which cell-type within the adipose tissue MCP-1 is produced, the findings in the present study add to the hypothesis that weight loss in obese subjects is beneficial improving the low-grade inflammatory state associated with obesity. 4, 20 In conclusion, MCP-1 production in isolated adipocytes was found to be comparable to that of other known adipokines. Adiposity was found to be associated with adipose as well as circulating MCP-1 levels, and weight reduction in morbid obese subjects was found to be associated with a decrement in circulating MCP-1 levels. However, additional studies are required to investigate whether adipose-derived MCP-1 is an active participant in the atherosclerotic process or simply one of the markers of the obesity-related inflammatory process. MCP-1, adipose tissue and obesity T Christiansen et al
